Amgen Balance Sheet Health
Financial Health criteria checks 1/6
Amgen has a total shareholder equity of $5.0B and total debt of $64.0B, which brings its debt-to-equity ratio to 1274.8%. Its total assets and total liabilities are $93.0B and $88.0B respectively. Amgen's EBIT is $7.2B making its interest coverage ratio 2.3. It has cash and short-term investments of $9.7B.
Key information
1,274.8%
Debt to equity ratio
US$64.02b
Debt
Interest coverage ratio | 2.3x |
Cash | US$9.71b |
Equity | US$5.02b |
Total liabilities | US$87.96b |
Total assets | US$92.98b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMGN's short term assets ($28.0B) exceed its short term liabilities ($19.7B).
Long Term Liabilities: AMGN's short term assets ($28.0B) do not cover its long term liabilities ($68.2B).
Debt to Equity History and Analysis
Debt Level: AMGN's net debt to equity ratio (1081.5%) is considered high.
Reducing Debt: AMGN's debt to equity ratio has increased from 304.9% to 1274.8% over the past 5 years.
Debt Coverage: AMGN's debt is not well covered by operating cash flow (12.6%).
Interest Coverage: AMGN's interest payments on its debt are not well covered by EBIT (2.3x coverage).